|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CD74-NTRK1 (FusionGDB2 ID:HG972TG4914) |
Fusion Gene Summary for CD74-NTRK1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CD74-NTRK1 | Fusion gene ID: hg972tg4914 | Hgene | Tgene | Gene symbol | CD74 | NTRK1 | Gene ID | 972 | 4914 |
| Gene name | CD74 molecule | neurotrophic receptor tyrosine kinase 1 | |
| Synonyms | DHLAG|HLADG|II|Ia-GAMMA|p33 | MTC|TRK|TRK1|TRKA|Trk-A|p140-TrkA | |
| Cytomap | ('CD74')('NTRK1') 5q33.1 | 1q23.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | HLA class II histocompatibility antigen gamma chainCD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)CD74 molecule, major histocompatibility complex, class II invariant chainHLA-DR antigens-associated | high affinity nerve growth factor receptorOncogene TRKTRK1-transforming tyrosine kinase proteingp140trkneurotrophic tyrosine kinase, receptor, type 1tropomyosin-related kinase Atyrosine kinase receptor A | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | P04233 | P04629 | |
| Ensembl transtripts involved in fusion gene | ENST00000377795, ENST00000009530, ENST00000353334, ENST00000524315, | ||
| Fusion gene scores | * DoF score | 43 X 51 X 20=43860 | 25 X 24 X 13=7800 |
| # samples | 59 | 33 | |
| ** MAII score | log2(59/43860*10)=-6.21604704731175 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(33/7800*10)=-4.56293619439116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: CD74 [Title/Abstract] AND NTRK1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CD74(149782126)-NTRK1(156844360), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | CD74-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD74-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CD74-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. CD74-NTRK1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CD74 | GO:0001516 | prostaglandin biosynthetic process | 12782713 |
| Hgene | CD74 | GO:0001934 | positive regulation of protein phosphorylation | 24942581 |
| Hgene | CD74 | GO:0002792 | negative regulation of peptide secretion | 19849849 |
| Hgene | CD74 | GO:0033674 | positive regulation of kinase activity | 24942581 |
| Hgene | CD74 | GO:0043066 | negative regulation of apoptotic process | 12782713 |
| Hgene | CD74 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 24942581 |
| Hgene | CD74 | GO:0043410 | positive regulation of MAPK cascade | 24942581 |
| Hgene | CD74 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 17045821 |
| Hgene | CD74 | GO:0045657 | positive regulation of monocyte differentiation | 24942581 |
| Hgene | CD74 | GO:0045893 | positive regulation of transcription, DNA-templated | 24942581 |
| Hgene | CD74 | GO:0046598 | positive regulation of viral entry into host cell | 24942581 |
| Hgene | CD74 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 17045821 |
| Hgene | CD74 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 17045821|24942581 |
| Tgene | NTRK1 | GO:0006468 | protein phosphorylation | 15488758 |
| Tgene | NTRK1 | GO:0008285 | negative regulation of cell proliferation | 15488758 |
| Tgene | NTRK1 | GO:0010976 | positive regulation of neuron projection development | 15488758 |
| Tgene | NTRK1 | GO:0018108 | peptidyl-tyrosine phosphorylation | 2927393 |
| Tgene | NTRK1 | GO:0043547 | positive regulation of GTPase activity | 15488758 |
| Tgene | NTRK1 | GO:0046579 | positive regulation of Ras protein signal transduction | 15488758 |
| Tgene | NTRK1 | GO:0046777 | protein autophosphorylation | 15488758 |
| Tgene | NTRK1 | GO:0048011 | neurotrophin TRK receptor signaling pathway | 15488758 |
| Tgene | NTRK1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 15488758 |
| Tgene | NTRK1 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 15488758 |
| Tgene | NTRK1 | GO:1904646 | cellular response to amyloid-beta | 11927634 |
| Fusion gene breakpoints across CD74 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across NTRK1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | non small cell lung cancer | HG532018 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 |
Top |
Fusion Gene ORF analysis for CD74-NTRK1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000009530 | ENST00000358660 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000009530 | ENST00000368196 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000009530 | ENST00000392302 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000009530 | ENST00000524377 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000353334 | ENST00000358660 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000353334 | ENST00000368196 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000353334 | ENST00000392302 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000353334 | ENST00000524377 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000377795 | ENST00000358660 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000377795 | ENST00000368196 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000377795 | ENST00000392302 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000377795 | ENST00000524377 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000524315 | ENST00000358660 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000524315 | ENST00000368196 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000524315 | ENST00000392302 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-3CDS | ENST00000524315 | ENST00000524377 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-intron | ENST00000009530 | ENST00000531606 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-intron | ENST00000353334 | ENST00000531606 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-intron | ENST00000377795 | ENST00000531606 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 | ||
| intron-intron | ENST00000524315 | ENST00000531606 | CD74 | chr5 | 149792499 | NTRK1 | chr1 | 156844360 |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000353334 | ENST00000392302 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.03999295 | 0.9600071 |
| ENST00000353334 | ENST00000368196 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.03808969 | 0.9619103 |
| ENST00000353334 | ENST00000524377 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.043101184 | 0.95689887 |
| ENST00000353334 | ENST00000358660 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.040439736 | 0.9595602 |
| ENST00000009530 | ENST00000392302 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.04795496 | 0.9520451 |
| ENST00000009530 | ENST00000368196 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.046329632 | 0.95367044 |
| ENST00000009530 | ENST00000524377 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.04869425 | 0.9513057 |
| ENST00000009530 | ENST00000358660 | CD74 | chr5 | 149782126 | - | NTRK1 | chr1 | 156844360 | + | 0.0472736 | 0.95272636 |
Top |
Fusion Genomic Features for CD74-NTRK1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CD74 | chr5 | 149782125 | - | NTRK1 | chr1 | 156844362 | + | 0.000180041 | 0.99981993 |
| CD74 | chr5 | 149782125 | - | NTRK1 | chr1 | 156844362 | + | 0.000180041 | 0.99981993 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for CD74-NTRK1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:149782126/chr1:156844360) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CD74 | NTRK1 |
| FUNCTION: Plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha/beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal/lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. Serves as cell surface receptor for the cytokine MIF.; FUNCTION: [Class-II-associated invariant chain peptide]: Binds to the peptide-binding site of MHC class II alpha/beta heterodimers forming an alpha-beta-CLIP complex, thereby preventing the loading of antigenic peptides to the MHC class II complex until its release by HLA-DM in the endosome. {ECO:0000269|PubMed:1448172}.; FUNCTION: [Isoform p41]: Stabilizes the conformation of mature CTSL by binding to its active site and serving as a chaperone to help maintain a pool of mature enzyme in endocytic compartments and extracellular space of antigen-presenting cells (APCs). Has antiviral activity by stymieing the endosomal entry of Ebola virus and coronaviruses, including SARS-CoV-2 (PubMed:32855215). Disrupts cathepsin-mediated Ebola virus glycoprotein processing, which prevents viral fusion and entry. This antiviral activity is specific to p41 isoform (PubMed:32855215). {ECO:0000250|UniProtKB:P04441, ECO:0000269|PubMed:32855215}. | FUNCTION: Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1850821, PubMed:1849459, PubMed:1281417, PubMed:8325889, PubMed:15488758, PubMed:22649032, PubMed:17196528, PubMed:27445338). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:1281417). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors. {ECO:0000250|UniProtKB:P35739, ECO:0000250|UniProtKB:Q3UFB7, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528, ECO:0000269|PubMed:1849459, ECO:0000269|PubMed:1850821, ECO:0000269|PubMed:22649032, ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.; FUNCTION: [Isoform TrkA-III]: Resistant to NGF, it constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed. {ECO:0000269|PubMed:15488758}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000009530 | - | 8 | 9 | 210_271 | 293 | 297.0 | Domain | Thyroglobulin type-1 |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000009530 | - | 8 | 9 | 1_46 | 293 | 297.0 | Topological domain | Cytoplasmic |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000009530 | - | 8 | 9 | 73_296 | 293 | 297.0 | Topological domain | Extracellular |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000353334 | - | 7 | 8 | 1_46 | 229 | 233.0 | Topological domain | Cytoplasmic |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000377795 | - | 5 | 6 | 1_46 | 168 | 280.6666666666667 | Topological domain | Cytoplasmic |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000009530 | - | 8 | 9 | 47_72 | 293 | 297.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000353334 | - | 7 | 8 | 47_72 | 229 | 233.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000377795 | - | 5 | 6 | 47_72 | 168 | 280.6666666666667 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 510_781 | 392 | 791.0 | Domain | Protein kinase | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 510_781 | 362 | 761.0 | Domain | Protein kinase | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 510_781 | 398 | 797.0 | Domain | Protein kinase | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 537_541 | 392 | 791.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 607_611 | 392 | 791.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 537_541 | 362 | 761.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 607_611 | 362 | 761.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 537_541 | 398 | 797.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 607_611 | 398 | 797.0 | Motif | DXXLL | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 516_524 | 392 | 791.0 | Nucleotide binding | ATP | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 516_524 | 362 | 761.0 | Nucleotide binding | ATP | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 516_524 | 398 | 797.0 | Nucleotide binding | ATP | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 440_796 | 392 | 791.0 | Topological domain | Cytoplasmic | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 440_796 | 362 | 761.0 | Topological domain | Cytoplasmic | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 440_796 | 398 | 797.0 | Topological domain | Cytoplasmic | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 424_439 | 392 | 791.0 | Transmembrane | Helical | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 424_439 | 362 | 761.0 | Transmembrane | Helical | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 424_439 | 398 | 797.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000353334 | - | 7 | 8 | 210_271 | 229 | 233.0 | Domain | Thyroglobulin type-1 |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000377795 | - | 5 | 6 | 210_271 | 168 | 280.6666666666667 | Domain | Thyroglobulin type-1 |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000353334 | - | 7 | 8 | 73_296 | 229 | 233.0 | Topological domain | Extracellular |
| Hgene | CD74 | chr5:149782126 | chr1:156844360 | ENST00000377795 | - | 5 | 6 | 73_296 | 168 | 280.6666666666667 | Topological domain | Extracellular |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 148_193 | 392 | 791.0 | Domain | Note=LRRCT | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 194_283 | 392 | 791.0 | Domain | Ig-like C2-type 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 299_365 | 392 | 791.0 | Domain | Ig-like C2-type 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 148_193 | 362 | 761.0 | Domain | Note=LRRCT | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 194_283 | 362 | 761.0 | Domain | Ig-like C2-type 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 299_365 | 362 | 761.0 | Domain | Ig-like C2-type 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 148_193 | 398 | 797.0 | Domain | Note=LRRCT | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 194_283 | 398 | 797.0 | Domain | Ig-like C2-type 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 299_365 | 398 | 797.0 | Domain | Ig-like C2-type 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 116_137 | 392 | 791.0 | Repeat | Note=LRR 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 90_113 | 392 | 791.0 | Repeat | Note=LRR 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 116_137 | 362 | 761.0 | Repeat | Note=LRR 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 90_113 | 362 | 761.0 | Repeat | Note=LRR 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 116_137 | 398 | 797.0 | Repeat | Note=LRR 2 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 90_113 | 398 | 797.0 | Repeat | Note=LRR 1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 33_423 | 392 | 791.0 | Topological domain | Extracellular | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 33_423 | 362 | 761.0 | Topological domain | Extracellular | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 33_423 | 398 | 797.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for CD74-NTRK1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >14643_14643_1_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000358660_length(transcript)=2156nt_BP=882nt AGATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAAC TGCCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGC TCCTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGC TGGAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCA TGGGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTG ACCCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGG TCTTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGTAC TGACCAAGTGCCAGGAAGAGGTCAGCCACATCCCTGCTGTCCACCCGGGTTCATTCAGGCCCAAGTGCGACGAGAACGGCAACTATCTGC CACTCCAGTGCTATGGGAGCATCGGCTACTGCTGGTGTGTCTTCCCCAACGGCACGGAGGTCCCCAACACCAGAAGCCGCGGGCACCATA ACTGCAGTGAGTCACTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTG GAGACCCGGTGGAGAAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGC TGCTCCTTGTGCTCAACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGT CCCTGCATTTCATGACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCAC AATACTTCAGTGATGCCTCCCCCTCAGGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTG GGAAGGTCTTCCTTGCTGAGTGCCACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGA GTGCTCGGCAGGACTTCCAGCGTGAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGG GCCGCCCCCTGCTCATGGTCTTTGAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGG CTGGTGGGGAGGATGTGGCTCCAGGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGG CGGGTCTGCATTTTGTGCACCGGGACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGA GCAGGGATATCTACAGCACCGACTATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACC GTAAGTTCACCACCGAGAGCGACGTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCT CCAACACGGAGGCAATCGACTGCATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGG GCTGCTGGCAGCGGGAGCCCCAGCAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACC >14643_14643_1_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000358660_length(amino acids)=694AA_BP=293 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHN CSESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMS LHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDASPSGVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES ARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS -------------------------------------------------------------- >14643_14643_2_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000368196_length(transcript)=2286nt_BP=882nt AGATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAAC TGCCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGC TCCTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGC TGGAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCA TGGGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTG ACCCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGG TCTTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGTAC TGACCAAGTGCCAGGAAGAGGTCAGCCACATCCCTGCTGTCCACCCGGGTTCATTCAGGCCCAAGTGCGACGAGAACGGCAACTATCTGC CACTCCAGTGCTATGGGAGCATCGGCTACTGCTGGTGTGTCTTCCCCAACGGCACGGAGGTCCCCAACACCAGAAGCCGCGGGCACCATA ACTGCAGTGAGTCACTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTG GAGACCCGGTGGAGAAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGC TGCTCCTTGTGCTCAACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGT CCCTGCATTTCATGACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCAC AATACTTCAGTGATGCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCT TCCTTGCTGAGTGCCACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGC AGGACTTCCAGCGTGAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCC TGCTCATGGTCTTTGAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGG AGGATGTGGCTCCAGGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGC ATTTTGTGCACCGGGACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATA TCTACAGCACCGACTATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCA CCACCGAGAGCGACGTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGG AGGCAATCGACTGCATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGC AGCGGGAGCCCCAGCAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCC TGGGCTAGGGGGCCGGCCCAGGGGCTGGGAGTGGTTAGCCGGAATACTGGGGCCTGCCCTCAGCATCCCCCATAGCTCCCAGCAGCCCCA GGGTGATCTCAAAGTATCTAATTCACCCTCAGCATGTGGGAAGGGACAGGTGGGGGCTGGGAGTAGAGGATGTTCCTGCTTCTCTAGGCA >14643_14643_2_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000368196_length(amino acids)=691AA_BP=293 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHN CSESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMS LHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE -------------------------------------------------------------- >14643_14643_3_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000392302_length(transcript)=2230nt_BP=882nt AGATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAAC TGCCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGC TCCTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGC TGGAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCA TGGGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTG ACCCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGG TCTTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGTAC TGACCAAGTGCCAGGAAGAGGTCAGCCACATCCCTGCTGTCCACCCGGGTTCATTCAGGCCCAAGTGCGACGAGAACGGCAACTATCTGC CACTCCAGTGCTATGGGAGCATCGGCTACTGCTGGTGTGTCTTCCCCAACGGCACGGAGGTCCCCAACACCAGAAGCCGCGGGCACCATA ACTGCAGTGAGTCACTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTG GAGACCCGGTGGAGAAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGC TGCTCCTTGTGCTCAACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGT CCCTGCATTTCATGACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCAC AATACTTCAGTGATGCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCT TCCTTGCTGAGTGCCACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGC AGGACTTCCAGCGTGAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCC TGCTCATGGTCTTTGAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGG AGGATGTGGCTCCAGGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGC ATTTTGTGCACCGGGACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATA TCTACAGCACCGACTATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCA CCACCGAGAGCGACGTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGG AGGCAATCGACTGCATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGC AGCGGGAGCCCCAGCAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCC TGGGCTAGGGGGCCGGCCCAGGGGCTGGGAGTGGTTAGCCGGAATACTGGGGCCTGCCCTCAGCATCCCCCATAGCTCCCAGCAGCCCCA >14643_14643_3_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000392302_length(amino acids)=691AA_BP=293 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHN CSESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMS LHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE -------------------------------------------------------------- >14643_14643_4_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000524377_length(transcript)=2078nt_BP=882nt AGATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAAC TGCCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGC TCCTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGC TGGAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCA TGGGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTG ACCCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGG TCTTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGTAC TGACCAAGTGCCAGGAAGAGGTCAGCCACATCCCTGCTGTCCACCCGGGTTCATTCAGGCCCAAGTGCGACGAGAACGGCAACTATCTGC CACTCCAGTGCTATGGGAGCATCGGCTACTGCTGGTGTGTCTTCCCCAACGGCACGGAGGTCCCCAACACCAGAAGCCGCGGGCACCATA ACTGCAGTGAGTCACTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTG GAGACCCGGTGGAGAAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGC TGCTCCTTGTGCTCAACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGT CCCTGCATTTCATGACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCAC AATACTTCAGTGATGCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCT TCCTTGCTGAGTGCCACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGC AGGACTTCCAGCGTGAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCC TGCTCATGGTCTTTGAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGG AGGATGTGGCTCCAGGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGC ATTTTGTGCACCGGGACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATA TCTACAGCACCGACTATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCA CCACCGAGAGCGACGTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGG AGGCAATCGACTGCATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGC AGCGGGAGCCCCAGCAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCC >14643_14643_4_CD74-NTRK1_CD74_chr5_149782126_ENST00000009530_NTRK1_chr1_156844360_ENST00000524377_length(amino acids)=692AA_BP=293 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKVLTKCQEEVSHIPAVHPGSFRPKCDENGNYLPLQCYGSIGYCWCVFPNGTEVPNTRSRGHHN CSESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMS LHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE -------------------------------------------------------------- >14643_14643_5_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000358660_length(transcript)=2142nt_BP=868nt GGGAGCCCCCCCGCCCCACATCCTGCCCCGCAAAAGGCAGCTTCACCAAAGTGGGGTATTTCCAGCCTTTGTAGCTTTCACTTCCACATC TACCAAGTGGGCGGAGTGGCCTTCTGTGGACGAATCAGATTCCTCTCCAGCACCGACTTTAAGAGGCGAGCCGGGGGGTCAGGGTCCCAG ATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAACTG CCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGCTC CTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGCTG GAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCATG GGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTGAC CCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGGTC TTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGAGTCA CTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTGGAGACCCGGTGGAG AAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGCTGCTCCTTGTGCTC AACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGTCCCTGCATTTCATG ACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCACAATACTTCAGTGAT GCCTCCCCCTCAGGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCTTCCTT GCTGAGTGCCACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGCAGGAC TTCCAGCGTGAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCCTGCTC ATGGTCTTTGAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGGAGGAT GTGGCTCCAGGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGCATTTT GTGCACCGGGACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATATCTAC AGCACCGACTATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCACCACC GAGAGCGACGTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGGAGGCA ATCGACTGCATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGCAGCGG GAGCCCCAGCAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCCTGGGC >14643_14643_5_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000358660_length(amino acids)=630AA_BP=229 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVL NKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDASPSGVHHIKRRDIVLKWELGEGAFGKVFL AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG -------------------------------------------------------------- >14643_14643_6_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000368196_length(transcript)=2272nt_BP=868nt GGGAGCCCCCCCGCCCCACATCCTGCCCCGCAAAAGGCAGCTTCACCAAAGTGGGGTATTTCCAGCCTTTGTAGCTTTCACTTCCACATC TACCAAGTGGGCGGAGTGGCCTTCTGTGGACGAATCAGATTCCTCTCCAGCACCGACTTTAAGAGGCGAGCCGGGGGGTCAGGGTCCCAG ATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAACTG CCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGCTC CTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGCTG GAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCATG GGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTGAC CCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGGTC TTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGAGTCA CTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTGGAGACCCGGTGGAG AAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGCTGCTCCTTGTGCTC AACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGTCCCTGCATTTCATG ACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCACAATACTTCAGTGAT GCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCTTCCTTGCTGAGTGC CACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGCAGGACTTCCAGCGT GAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCCTGCTCATGGTCTTT GAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGGAGGATGTGGCTCCA GGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGCATTTTGTGCACCGG GACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATATCTACAGCACCGAC TATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCACCACCGAGAGCGAC GTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGGAGGCAATCGACTGC ATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGCAGCGGGAGCCCCAG CAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCCTGGGCTAGGGGGCC GGCCCAGGGGCTGGGAGTGGTTAGCCGGAATACTGGGGCCTGCCCTCAGCATCCCCCATAGCTCCCAGCAGCCCCAGGGTGATCTCAAAG TATCTAATTCACCCTCAGCATGTGGGAAGGGACAGGTGGGGGCTGGGAGTAGAGGATGTTCCTGCTTCTCTAGGCAAGGTCCCGTCATAG >14643_14643_6_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000368196_length(amino acids)=627AA_BP=229 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVL NKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD -------------------------------------------------------------- >14643_14643_7_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000392302_length(transcript)=2216nt_BP=868nt GGGAGCCCCCCCGCCCCACATCCTGCCCCGCAAAAGGCAGCTTCACCAAAGTGGGGTATTTCCAGCCTTTGTAGCTTTCACTTCCACATC TACCAAGTGGGCGGAGTGGCCTTCTGTGGACGAATCAGATTCCTCTCCAGCACCGACTTTAAGAGGCGAGCCGGGGGGTCAGGGTCCCAG ATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAACTG CCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGCTC CTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGCTG GAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCATG GGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTGAC CCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGGTC TTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGAGTCA CTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTGGAGACCCGGTGGAG AAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGCTGCTCCTTGTGCTC AACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGTCCCTGCATTTCATG ACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCACAATACTTCAGTGAT GCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCTTCCTTGCTGAGTGC CACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGCAGGACTTCCAGCGT GAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCCTGCTCATGGTCTTT GAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGGAGGATGTGGCTCCA GGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGCATTTTGTGCACCGG GACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATATCTACAGCACCGAC TATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCACCACCGAGAGCGAC GTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGGAGGCAATCGACTGC ATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGCAGCGGGAGCCCCAG CAACGCCACAGCATCAAGGATGTGCACGCCCGGCTGCAAGCCCTGGCCCAGGCACCTCCTGTCTACCTGGATGTCCTGGGCTAGGGGGCC GGCCCAGGGGCTGGGAGTGGTTAGCCGGAATACTGGGGCCTGCCCTCAGCATCCCCCATAGCTCCCAGCAGCCCCAGGGTGATCTCAAAG >14643_14643_7_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000392302_length(amino acids)=627AA_BP=229 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVL NKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD -------------------------------------------------------------- >14643_14643_8_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000524377_length(transcript)=2064nt_BP=868nt GGGAGCCCCCCCGCCCCACATCCTGCCCCGCAAAAGGCAGCTTCACCAAAGTGGGGTATTTCCAGCCTTTGTAGCTTTCACTTCCACATC TACCAAGTGGGCGGAGTGGCCTTCTGTGGACGAATCAGATTCCTCTCCAGCACCGACTTTAAGAGGCGAGCCGGGGGGTCAGGGTCCCAG ATGCACAGGAGGAGAAGCAGGAGCTGTCGGGAAGATCAGAAGCCAGTCATGGATGACCAGCGCGACCTTATCTCCAACAATGAGCAACTG CCCATGCTGGGCCGGCGCCCTGGGGCCCCGGAGAGCAAGTGCAGCCGCGGAGCCCTGTACACAGGCTTTTCCATCCTGGTGACTCTGCTC CTCGCTGGCCAGGCCACCACCGCCTACTTCCTGTACCAGCAGCAGGGCCGGCTGGACAAACTGACAGTCACCTCCCAGAACCTGCAGCTG GAGAACCTGCGCATGAAGCTTCCCAAGCCTCCCAAGCCTGTGAGCAAGATGCGCATGGCCACCCCGCTGCTGATGCAGGCGCTGCCCATG GGAGCCCTGCCCCAGGGGCCCATGCAGAATGCCACCAAGTATGGCAACATGACAGAGGACCATGTGATGCACCTGCTCCAGAATGCTGAC CCCCTGAAGGTGTACCCGCCACTGAAGGGGAGCTTCCCGGAGAACCTGAGACACCTTAAGAACACCATGGAGACCATAGACTGGAAGGTC TTTGAGAGCTGGATGCACCATTGGCTCCTGTTTGAAATGAGCAGGCACTCCTTGGAGCAAAAGCCCACTGACGCTCCACCGAAAGAGTCA CTGGAACTGGAGGACCCGTCTTCTGGGCTGGGTGTGACCAAGCAGGATCTGGGCCCAGACACTAACAGCACATCTGGAGACCCGGTGGAG AAGAAGGACGAAACACCTTTTGGGGTCTCGGTGGCTGTGGGCCTGGCCGTCTTTGCCTGCCTCTTCCTTTCTACGCTGCTCCTTGTGCTC AACAAATGTGGACGGAGAAACAAGTTTGGGATCAACCGCCCGGCTGTGCTGGCTCCAGAGGATGGGCTGGCCATGTCCCTGCATTTCATG ACATTGGGTGGCAGCTCCCTGTCCCCCACCGAGGGCAAAGGCTCTGGGCTCCAAGGCCACATCATCGAGAACCCACAATACTTCAGTGAT GCCTGTGTTCACCACATCAAGCGCCGGGACATCGTGCTCAAGTGGGAGCTGGGGGAGGGCGCCTTTGGGAAGGTCTTCCTTGCTGAGTGC CACAACCTCCTGCCTGAGCAGGACAAGATGCTGGTGGCTGTCAAGGCACTGAAGGAGGCGTCCGAGAGTGCTCGGCAGGACTTCCAGCGT GAGGCTGAGCTGCTCACCATGCTGCAGCACCAGCACATCGTGCGCTTCTTCGGCGTCTGCACCGAGGGCCGCCCCCTGCTCATGGTCTTT GAGTATATGCGGCACGGGGACCTCAACCGCTTCCTCCGATCCCATGGACCTGATGCCAAGCTGCTGGCTGGTGGGGAGGATGTGGCTCCA GGCCCCCTGGGTCTGGGGCAGCTGCTGGCCGTGGCTAGCCAGGTCGCTGCGGGGATGGTGTACCTGGCGGGTCTGCATTTTGTGCACCGG GACCTGGCCACACGCAACTGTCTAGTGGGCCAGGGACTGGTGGTCAAGATTGGTGATTTTGGCATGAGCAGGGATATCTACAGCACCGAC TATTACCGTGTGGGAGGCCGCACCATGCTGCCCATTCGCTGGATGCCGCCCGAGAGCATCCTGTACCGTAAGTTCACCACCGAGAGCGAC GTGTGGAGCTTCGGCGTGGTGCTCTGGGAGATCTTCACCTACGGCAAGCAGCCCTGGTACCAGCTCTCCAACACGGAGGCAATCGACTGC ATCACGCAGGGACGTGAGTTGGAGCGGCCACGTGCCTGCCCACCAGAGGTCTACGCCATCATGCGGGGCTGCTGGCAGCGGGAGCCCCAG >14643_14643_8_CD74-NTRK1_CD74_chr5_149782126_ENST00000353334_NTRK1_chr1_156844360_ENST00000524377_length(amino acids)=627AA_BP=229 MHRRRSRSCREDQKPVMDDQRDLISNNEQLPMLGRRPGAPESKCSRGALYTGFSILVTLLLAGQATTAYFLYQQQGRLDKLTVTSQNLQL ENLRMKLPKPPKPVSKMRMATPLLMQALPMGALPQGPMQNATKYGNMTEDHVMHLLQNADPLKVYPPLKGSFPENLRHLKNTMETIDWKV FESWMHHWLLFEMSRHSLEQKPTDAPPKESLELEDPSSGLGVTKQDLGPDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVL NKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAEC HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CD74-NTRK1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000368196 | 7 | 16 | 469_490 | 392.3333333333333 | 791.0 | SQSTM1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000392302 | 8 | 17 | 469_490 | 362.3333333333333 | 761.0 | SQSTM1 | |
| Tgene | NTRK1 | chr5:149782126 | chr1:156844360 | ENST00000524377 | 8 | 17 | 469_490 | 398.3333333333333 | 797.0 | SQSTM1 |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CD74-NTRK1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | NTRK1 | P04629 | DB00321 | Amitriptyline | Activator|Agonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00321 | Amitriptyline | Activator|Agonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00321 | Amitriptyline | Activator|Agonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00321 | Amitriptyline | Activator|Agonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00619 | Imatinib | Antagonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00619 | Imatinib | Antagonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00619 | Imatinib | Antagonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB00619 | Imatinib | Antagonist | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
| Tgene | NTRK1 | P04629 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB11986 | Entrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB13926 | Cenegermin | Stimulator | Biotech | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB13926 | Cenegermin | Stimulator | Biotech | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB13926 | Cenegermin | Stimulator | Biotech | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB13926 | Cenegermin | Stimulator | Biotech | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB14723 | Larotrectinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
| Tgene | NTRK1 | P04629 | DB15822 | Pralsetinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for CD74-NTRK1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CD74 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| Hgene | CD74 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
| Hgene | CD74 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Hgene | CD74 | C0162557 | Liver Failure, Acute | 1 | CTD_human |
| Hgene | CD74 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Hgene | CD74 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Hgene | CD74 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | CD74 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
| Tgene | C0020074 | HSAN Type IV | 17 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
| Tgene | C0238463 | Papillary thyroid carcinoma | 3 | ORPHANET | |
| Tgene | C0002768 | Congenital Pain Insensitivity | 1 | ORPHANET | |
| Tgene | C0005586 | Bipolar Disorder | 1 | CTD_human | |
| Tgene | C0005587 | Depression, Bipolar | 1 | CTD_human | |
| Tgene | C0017638 | Glioma | 1 | CTD_human | |
| Tgene | C0020075 | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1 | CTD_human;ORPHANET | |
| Tgene | C0024713 | Manic Disorder | 1 | CTD_human | |
| Tgene | C0027796 | Neuralgia | 1 | CTD_human | |
| Tgene | C0027819 | Neuroblastoma | 1 | CTD_human | |
| Tgene | C0033958 | Psychosis, Brief Reactive | 1 | CTD_human | |
| Tgene | C0033975 | Psychotic Disorders | 1 | CTD_human | |
| Tgene | C0036337 | Schizoaffective Disorder | 1 | CTD_human | |
| Tgene | C0036341 | Schizophrenia | 1 | CTD_human | |
| Tgene | C0036358 | Schizophreniform Disorders | 1 | CTD_human | |
| Tgene | C0038870 | Neuralgia, Supraorbital | 1 | CTD_human | |
| Tgene | C0042656 | Neuralgia, Vidian | 1 | CTD_human | |
| Tgene | C0234247 | Neuralgia, Atypical | 1 | CTD_human | |
| Tgene | C0234249 | Neuralgia, Stump | 1 | CTD_human | |
| Tgene | C0259783 | mixed gliomas | 1 | CTD_human | |
| Tgene | C0273115 | Lung Injury | 1 | CTD_human | |
| Tgene | C0338831 | Manic | 1 | CTD_human | |
| Tgene | C0423711 | Neuralgia, Perineal | 1 | CTD_human | |
| Tgene | C0423712 | Neuralgia, Iliohypogastric Nerve | 1 | CTD_human | |
| Tgene | C0555198 | Malignant Glioma | 1 | CTD_human | |
| Tgene | C0598589 | Inherited neuropathies | 1 | GENOMICS_ENGLAND | |
| Tgene | C0751371 | Neuralgia, Ilioinguinal | 1 | CTD_human | |
| Tgene | C0751372 | Nerve Pain | 1 | CTD_human | |
| Tgene | C0751373 | Paroxysmal Nerve Pain | 1 | CTD_human | |
| Tgene | C0752347 | Lewy Body Disease | 1 | CTD_human | |
| Tgene | C1833921 | Familial medullary thyroid carcinoma | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET | |
| Tgene | C2350344 | Chronic Lung Injury | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies